Impact BioMedical Inc.
IBO
$0.43
-$0.01-1.60%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.19M | -38.47M | -25.01M | -24.71M | 1.17M |
| Total Depreciation and Amortization | 861.00K | 7.00K | 6.00K | 7.00K | 6.00K |
| Total Amortization of Deferred Charges | 277.00K | 1.12M | 1.12M | 1.11M | 1.11M |
| Total Other Non-Cash Items | 40.16M | 34.24M | 21.17M | 21.07M | -4.94M |
| Change in Net Operating Assets | -353.00K | -534.00K | -603.00K | -608.00K | 352.00K |
| Cash from Operations | -3.25M | -3.63M | -3.32M | -3.12M | -2.30M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00K | 2.00K | 3.00K | 2.00K | 3.00K |
| Cash from Investing | 2.00K | 2.00K | 3.00K | 2.00K | 3.00K |
| Total Debt Issued | 587.00K | 527.00K | 911.00K | 1.39M | 1.04M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 3.73M | 3.73M | 3.73M | 3.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 587.00K | 4.25M | 4.64M | 5.12M | 4.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.66M | 622.00K | 1.32M | 2.00M | 2.47M |